108 related articles for article (PubMed ID: 20031728)
21. Multivessel disease in diabetics: does DES level the field?
Hillegass W
Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
[No Abstract] [Full Text] [Related]
22. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA
Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
[No Abstract] [Full Text] [Related]
23. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
[TBL] [Abstract][Full Text] [Related]
24. Drug eluting stents in AMI: keep the data coming.
Vetrovec GW
Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
[No Abstract] [Full Text] [Related]
25. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
Wood FO; Saylors EK; Schneider JE; Jobe RL; Mann JT
Catheter Cardiovasc Interv; 2008 Mar; 71(4):533-8. PubMed ID: 18307224
[TBL] [Abstract][Full Text] [Related]
26. More openness and a little less strut: two good ideas for stents and the people who implant them.
Morrison DA
Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
[No Abstract] [Full Text] [Related]
27. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
[TBL] [Abstract][Full Text] [Related]
28. The need for a dedicated bifurcation stenting system.
Kornowski R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):641-2. PubMed ID: 19309702
[No Abstract] [Full Text] [Related]
29. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
Kedia G; Lee MS
Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
[TBL] [Abstract][Full Text] [Related]
30. Late stent thrombosis--the "vulnerable" stent.
Waksman R
Catheter Cardiovasc Interv; 2007 Jul; 70(1):54-6. PubMed ID: 17585385
[No Abstract] [Full Text] [Related]
31. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
Johnson TW; Kay IP; Ormiston JA
Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074
[TBL] [Abstract][Full Text] [Related]
32. Another small step for small vessels.
Morrison DA
Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
[No Abstract] [Full Text] [Related]
33. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
34. Bifurcation stenting: a commitment to always kiss.
Hillegass WB
Catheter Cardiovasc Interv; 2010 Mar; 75(4):614-5. PubMed ID: 20333659
[No Abstract] [Full Text] [Related]
35. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
Park SJ
Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
[No Abstract] [Full Text] [Related]
36. Time for left main stenting in patients with LV dysfunction? Proceed with caution!
Uretsky BF
Catheter Cardiovasc Interv; 2010 Mar; 75(4):594-5. PubMed ID: 20333658
[No Abstract] [Full Text] [Related]
37. Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry.
Ahmed WH; Mendiz OA; Thomas MR;
Catheter Cardiovasc Interv; 2011 Jun; 77(7):979-92. PubMed ID: 20853350
[TBL] [Abstract][Full Text] [Related]
38. If I've heard it once, I've heard it (not yet) a hundred times.
Butman SM
Catheter Cardiovasc Interv; 2011 Mar; 77(4):502. PubMed ID: 21351224
[No Abstract] [Full Text] [Related]
39. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
Naidu SS
J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394
[No Abstract] [Full Text] [Related]
40. Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report.
Esposito G; Cassese S; Gargiulo G; Sannino A; Schiattarella GG; Piscione F; Chiariello M
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):366-9. PubMed ID: 20407382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
